For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Euda Health Holdings Limited’s stock clocked out at $4.23, down -7.02% from its previous closing price of $4.55. In other words, the price has decreased by -$7.02 from its previous closing price. On the day, 0.1 million shares were traded. EUDA stock price reached its highest trading level at $4.49 during the session, while it also had its lowest trading level at $4.23.
Ratios:
To gain a deeper understanding of EUDA’s stock, we examine its different ratios.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EUDA now has a Market Capitalization of 157179472 and an Enterprise Value of 153610912. Its current Enterprise Value per Revenue stands at 40.302 whereas that against EBITDA is -54.51.
Stock Price History:
The Beta on a monthly basis for EUDA is 0.01, which has changed by 1.7121794 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, EUDA has reached a high of $6.30, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -6.98%, while the 200-Day Moving Average is calculated to be 19.72%.
Shares Statistics:
It appears that EUDA traded 85.87K shares on average per day over the past three months and 99490 shares per day over the past ten days. A total of 24.78M shares are outstanding, with a floating share count of 20.06M. Insiders hold about 46.01% of the company’s shares, while institutions hold 2.34% stake in the company. Shares short for EUDA as of 1734048000 were 14890 with a Short Ratio of 0.17, compared to 1731628800 on 4924. Therefore, it implies a Short% of Shares Outstanding of 14890 and a Short% of Float of 0.06999999999999999.
Earnings Estimates
The performance of Euda Health Holdings Limited (EUDA) in the stock market is under the watchful eye of 1 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.02, with high estimates of -$0.02 and low estimates of -$0.02.
Analysts are recommending an EPS of between -$0.08 and -$0.08 for the fiscal current year, implying an average EPS of -$0.08. EPS for the following year is -$0.06, with 1.0 analysts recommending between -$0.06 and -$0.06.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $1.88M. There is a high estimate of $1.88M for the next quarter, whereas the lowest estimate is $1.88M.
Based on 1 analysts’ estimates, the company’s revenue will be $14.36M in the next fiscal year. The high estimate is $14.36M and the low estimate is $14.36M.
